ZCM
Zebra Capital Management Portfolio holdings
AUM
$20M
This Quarter Return
+18.5%
1 Year Return
+2.24%
3 Year Return
+142.11%
5 Year Return
+107.08%
10 Year Return
+252.13%
AUM
$90.8M
AUM Growth
+$90.8M
(+15%)
Cap. Flow
+$7.1M
Cap. Flow
% of AUM
7.81%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
278
New
115
Increased
18
Reduced
36
Closed
109
Top Buys
| 1 |
Kelly Services Class A
KELYA
|
$2.03M |
| 2 |
Emergent Biosolutions
EBS
|
$1.95M |
| 3 |
ESGR
Enstar Group
ESGR
|
$1.75M |
| 4 |
LCI Industries
LCII
|
$1.47M |
| 5 |
Upbound Group
UPBD
|
$1.46M |
Top Sells
| 1 |
WD-40
WDFC
|
$1.47M |
| 2 |
Corcept Therapeutics
CORT
|
$1.23M |
| 3 |
Veracyte
VCYT
|
$1.14M |
| 4 |
Castle Biosciences
CSTL
|
$1.03M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$965K |
Sector Composition
| 1 | Healthcare | 20.12% |
| 2 | Industrials | 15.8% |
| 3 | Financials | 14.75% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Technology | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kelly Services Class A
KELYA
$502M
| $2.03M | 2.24% | +91,125 | New | +$2.03M |
|
|
2
Emergent Biosolutions
EBS
$443M
| $1.95M | 2.14% | +20,957 | New | +$1.95M |
|
3
Rush Enterprises Class A
RUSHA
$4.47B
| $1.91M | 2.11% | 38,383 +18,297 | +91% | +$912K |
|
4
Insight Enterprises
NSIT
$4.1B
| $1.88M | 2.07% | 19,740 +4,789 | +32% | +$457K |
|
|
ESGR
5
DELISTED
Enstar Group
ESGR
| $1.75M | 1.93% | +7,106 | New | +$1.75M |
|
6
Cross Country Healthcare
CCRN
$438M
| $1.49M | 1.64% | 119,119 +32,100 | +37% | +$401K |
|
|
7
LCI Industries
LCII
$2.56B
| $1.47M | 1.62% | +11,127 | New | +$1.47M |
|
|
8
Upbound Group
UPBD
$1.47B
| $1.46M | 1.61% | +25,381 | New | +$1.46M |
|
9
Otter Tail
OTTR
$3.52B
| $1.39M | 1.53% | +30,036 | New | +$1.39M |
|
10
Patrick Industries
PATK
$3.72B
| $1.36M | 1.5% | +15,978 | New | +$1.36M |
|
11
Phibro Animal Health
PAHC
$1.5B
| $1.35M | 1.49% | +55,442 | New | +$1.35M |
|
12
Donegal Group Class A
DGICA
$653M
| $1.31M | 1.45% | 88,303 +23,743 | +37% | +$353K |
|
|
BPMC
13
DELISTED
Blueprint Medicines
BPMC
| $1.24M | 1.36% | +12,698 | New | +$1.24M |
|
14
Coca-Cola Consolidated
COKE
$10.2B
| $1.24M | 1.36% | +4,276 | New | +$1.24M |
|
15
PC Connection
CNXN
$1.63B
| $1.22M | 1.34% | +26,300 | New | +$1.22M |
|
|
NWLI
16
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.17M | 1.29% | +4,712 | New | +$1.17M |
|
17
Forestar Group
FOR
$1.41B
| $1.16M | 1.27% | +49,628 | New | +$1.16M |
|
18
Stepan Co
SCL
$1.13B
| $1.16M | 1.27% | +9,088 | New | +$1.16M |
|
19
MYR Group
MYRG
$2.91B
| $1.12M | 1.23% | 15,621 +7,050 | +82% | +$505K |
|
20
Helen of Troy
HELE
$564M
| $1.08M | 1.19% | +5,148 | New | +$1.08M |
|
21
PotlatchDeltic
PCH
$3.25B
| $1.05M | 1.16% | 19,893 +13,335 | +203% | +$706K |
|
22
Mueller Industries
MLI
$10.6B
| $1.05M | 1.15% | 25,302 +11,755 | +87% | +$486K |
|
|
SYKE
23
DELISTED
SYKES Enterprises Inc
SYKE
| $1.03M | 1.13% | 23,324 -7,444 | -24% | -$328K |
|
24
Myriad Genetics
MYGN
$593M
| $1.01M | 1.11% | +33,060 | New | +$1.01M |
|
25
Weis Markets
WMK
$1.77B
| $1M | 1.1% | 17,710 +4,480 | +34% | +$253K |
|